Cat. #152592
Anti-DAF [67]
Cat. #: 152592
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Decay accelerating factor (DAF, CD55)
Class: Recombinant
Application: FACS ; IHC ; IF ; WB
Reactivity: Human
Host: Mouse
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Nancy Hogg
Institute: Absolute Antibody ; Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-DAF [67]
- Clone: r67
- Tool sub type: Primary antibody
- Class: Recombinant
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IF ; WB
- Description: Decay Accelerating Factor is a distinctive marker of synovium. Decay Accelerating Factor protects tissues from attack by autologous complement by interfering with the assembly of C3 convertase.
- Immunogen: Fibronectin purified human monocytes .
- Isotype: IgG1
Target Details
- Target: Decay accelerating factor (DAF, CD55)
- Target background: Decay Accelerating Factor is a distinctive marker of synovium. Decay Accelerating Factor protects tissues from attack by autologous complement by interfering with the assembly of C3 convertase.
Applications
- Application: FACS ; IHC ; IF ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS only
- Storage conditions: -20° C
- Shipping conditions: Shipping at 4° C
References
- Original hybridoma first published in Palmer et al. 1985. Clin Exp Immunol. 59(3):529-38. PMID: 3886218.
- Features of synovial membrane identified with monoclonal antibodies.
